Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieuwe de Haan

Showing results (1-10 of 487) with videos related to

Pageof 49
Sort By:
Psychological Medicine|January 25, 2022
It might be a wonderful opportunity when patients with a psychotic disorder use cannabisLieuwe de Haan
Nederlands Tijdschrift Voor Geneeskunde|January 7, 2016
[High mortality following psychosis: not only due to suicide]Lieuwe de Haan
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 22, 2009
Remission of schizophrenia psychosis and strong reduction of obsessive-compulsive disorder after adding clozapine to aripiprazoleBart Peters, Lieuwe de Haan
Psychopharmacology|July 11, 2002
Olanzapine-induced obsessive-compulsive symptoms in a patient with bipolar II disorderFrits Jonkers, Lieuwe De Haan
The American Journal of Psychiatry|July 5, 2005
Olanzapine and haloperidol for residual symptomsLieuwe de Haan, Nico van Beveren
Psychopharmacology Bulletin|December 15, 2010
Off-label second generation antipsychotics for impulse regulation disorders: a reviewAlbertine Scheltema Beduin, Lieuwe de Haan
Psychopathology|March 15, 2006
Early withdrawal in a double-blind randomized clinical trial with olanzapine and risperidone performed in adolescents with first psychosisLonneke van Nimwegen, Lieuwe de Haan
The American Journal of Psychiatry|November 27, 2002
Comparable dopamine 2 receptor occupancyLieuwe de Haan, Therese van Amelsvoort
JAMA|March 5, 2004
Olanzapine vs haloperidol for treatment of schizophreniaLieuwe de Haan, Nico van Beveren
Psychopharmacology Bulletin|June 29, 2010
Differences in efficacy on substance abuse between risperidone and clozapine supports the importance of differential modulation of dopaminergic neurotransmissionMarise W J Machielsen, Lieuwe de Haan
Pageof 49

Showing results (1-10 of 487) with videos related to

Sort By:
Pageof 49
Psychological Medicine|January 25, 2022
It might be a wonderful opportunity when patients with a psychotic disorder use cannabisLieuwe de Haan
Nederlands Tijdschrift Voor Geneeskunde|January 7, 2016
[High mortality following psychosis: not only due to suicide]Lieuwe de Haan
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 22, 2009
Remission of schizophrenia psychosis and strong reduction of obsessive-compulsive disorder after adding clozapine to aripiprazoleBart Peters, Lieuwe de Haan
Psychopharmacology|July 11, 2002
Olanzapine-induced obsessive-compulsive symptoms in a patient with bipolar II disorderFrits Jonkers, Lieuwe De Haan
The American Journal of Psychiatry|July 5, 2005
Olanzapine and haloperidol for residual symptomsLieuwe de Haan, Nico van Beveren
Psychopharmacology Bulletin|December 15, 2010
Off-label second generation antipsychotics for impulse regulation disorders: a reviewAlbertine Scheltema Beduin, Lieuwe de Haan
Psychopathology|March 15, 2006
Early withdrawal in a double-blind randomized clinical trial with olanzapine and risperidone performed in adolescents with first psychosisLonneke van Nimwegen, Lieuwe de Haan
The American Journal of Psychiatry|November 27, 2002
Comparable dopamine 2 receptor occupancyLieuwe de Haan, Therese van Amelsvoort
JAMA|March 5, 2004
Olanzapine vs haloperidol for treatment of schizophreniaLieuwe de Haan, Nico van Beveren
Psychopharmacology Bulletin|June 29, 2010
Differences in efficacy on substance abuse between risperidone and clozapine supports the importance of differential modulation of dopaminergic neurotransmissionMarise W J Machielsen, Lieuwe de Haan
Pageof 49